טיפול עם אנטגוניסט לרצפטור של אוקסיטוצין בפאזה הלוטאלית לצורך השתלת העובר והריון בנשים שעוברות טיפול להגברת הפריון
- 专利权人:
- FERRING B.V.;JOAN-CARLES ARCE
- 发明人:
- JOAN-CARLES ARCE
- 申请号：
- IL25307817
- 公开号：
- IL253078D0
- 申请日:
- 2017.06.21
- 申请国别(地区):
- IL
- 年份:
- 2017
- 代理人:
- 摘要：
- The present invention relates to the use of an oxytocin receptor antagonist in females undergoing an assisted reproductive technology. Specifically, the antagonists are released in the luteal phase when the endometrium is receptive for embryo implantation.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- OXYTOCIN RECEPTOR ANTAGONIST THERAPY IN THE LUTEAL PHASE FOR IMPLANTATION AND PREGNANCY IN WOMEN UNDERGOING ASSISTED REPRODUCTIVE TECHNOLOGIES
- Terapia antagonistą receptora oksytocyny w fazie lutealnej w celu implantacji i uzyskania ciąży u kobiet poddawanych technikom wspomaganego rozrodu
- OXYTOCIN RECEPTOR ANTAGONIST THERAPY IN THE LUTEAL PHASE FOR IMPLANTATION AND PREGNANCY IN WOMEN UNDERGOING ASSISTED REPRODUCTIVE TECHNOLOGIES
- OXYTOCIN RECEPTOR ANTAGONIST THERAPY IN THE LUTEAL PHASE FOR IMPLANTATION AND PREGNANCY IN WOMEN UNDERGOING ASSISTED REPRODUCTIVE TECHNOLOGIES
- Oxytocin receptor antagonist therapy in the luteal phase for implantation and pregnancy in women undergoing assisted reproductive technologies
